Nucleic Acids Research, 2003, Vol. 31, No. 18 5266-5274
© 2003 Oxford University Press
Ligand-independent activation of estrogen receptor 
by XBP-1
1 Beijing Institute of Biotechnology, Beijing 100850, Peoples Republic of China, 2 Fujian Science and Technology University, Fuzhou 350002, Peoples Republic of China and 3 Beijing Institute of Radiation Medicine, Beijing 100850, Peoples Republic of China
*To whom correspondence should be addressed at Beijing Institute of Biotechnology, 27 Tai-Ping Lu Rd, Beijing 100850, Peoples Republic of China. Tel: +86 10 6818 0809; Fax: +86 10 6824 8045; Email: yeqn{at}nic.bmi.ac.cn
The estrogen receptor (ER) is a member of a large superfamily of nuclear receptors that regulates the transcription of estrogen-responsive genes. Several recent studies have demonstrated that XBP-1 mRNA expression is associated with ER
status in breast tumors. However, the role of XBP-1 in ER signaling remains to be elucidated. More recently, two forms of XBP-1 were identified due to its unconventional splicing. We refer to the spliced and unspliced forms of XBP-1 as XBP-1S and XBP-1U, respectively. Here, we report that XBP-1S and XBP-1U enhanced ER-dependent transcriptional activity in a ligand-independent manner. XBP-1S had stronger activity than XBP-1U. The maximal effects of XBP-1S and XBP-1U on ER transactivation were observed when they were co-expressed with full-length ER. SRC-1, the p160 steroid receptor coactivator family member, synergized with XBP-1S or XBP-1U to potentiate ER activity. XBP-1S and XBP-1U bound to the ER both in vitro and in vivo in a ligand-independent fashion. XBP-1S and XBP-1U interacted with the ER region containing the DNA-binding domain. The ER-interacting regions on XBP-1S and XBP-1U have been mapped to two regions, including the N-terminal basic region leucine zipper domain (bZIP) and the C-terminal activation domain. The bZIP-deleted mutants of XBP-1S and XBP-1U completely abolished ER transactivation by XBP-1S and XBP-1U. These findings suggest that XBP-1S and XBP-1U may directly modulate ER signaling in both the absence and presence of estrogen and, therefore, may play important roles in the proliferation of normal and malignant estrogen-regulated tissues.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. P. Gomez, R. B. Riggins, A. N. Shajahan, U. Klimach, A. Wang, A. C. Crawford, Y. Zhu, A. Zwart, M. Wang, and R. Clarke Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines FASEB J, December 1, 2007; 21(14): 4013 - 4027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Hsieh, I.-J. Su, H.-C. Wang, J.-H. Tsai, Y.-J. Huang, W.-W. Chang, M.-D. Lai, H.-Y. Lei, and W. Huang Hepatitis B Virus Pre-S2 Mutant Surface Antigen Induces Degradation of Cyclin-Dependent Kinase Inhibitor p27Kip1 through c-Jun Activation Domain-Binding Protein 1 Mol. Cancer Res., October 1, 2007; 5(10): 1063 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Bhende, S. J. Dickerson, X. Sun, W.-H. Feng, and S. C. Kenney X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D J. Virol., July 15, 2007; 81(14): 7363 - 7370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lopez-Garcia, M. Periyasamy, R. S. Thomas, M. Christian, M. Leao, P. Jat, K. B. Kindle, D. M. Heery, M. G. Parker, L. Buluwela, et al. ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases Nucleic Acids Res., December 4, 2006; 34(21): 6126 - 6136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sun, L. Ding, H. Zhang, J. Han, X. Yang, J. Yan, Y. Zhu, J. Li, H. Song, and Q. Ye Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS Nucleic Acids Res., December 4, 2006; 34(21): 6314 - 6326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Tozlu, I Girault, S Vacher, J Vendrell, C Andrieu, F Spyratos, P Cohen, R Lidereau, and I Bieche Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach Endocr. Relat. Cancer, December 1, 2006; 13(4): 1109 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Carroll and M. Brown Estrogen Receptor Target Gene: An Evolving Concept Mol. Endocrinol., August 1, 2006; 20(8): 1707 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, L. Ding, B. Yuan, X. Yang, X. Wang, J. Li, Q. Lu, C. Huang, and Q. Ye Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells Nucleic Acids Res., June 6, 2006; 34(10): 3095 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, X. Xie, X. Zhu, J. Zhu, C. Hao, Q. Lu, L. Ding, Y. Liu, L. Zhou, Y. Liu, et al. Stimulatory Cross-talk between NFAT3 and Estrogen Receptor in Breast Cancer Cells J. Biol. Chem., December 30, 2005; 280(52): 43188 - 43197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leong, J. R. Sloan, P. D. Nash, and G. L. Greene Recruitment of Histone Deacetylase 4 to the N-Terminal Region of Estrogen Receptor {alpha} Mol. Endocrinol., December 1, 2005; 19(12): 2930 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Keeton and M. Brown Cell Cycle Progression Stimulated by Tamoxifen-Bound Estrogen Receptor-{alpha} and Promoter-Specific Effects in Breast Cancer Cells Deficient in N-CoR and SMRT Mol. Endocrinol., June 1, 2005; 19(6): 1543 - 1554. [Abstract] [Full Text] [PDF]
|
|